ANDA 72995, held by Roxane Laboratories. Metoclopramide Hydrochloride.
As of Nov 20, 2026, ANDA 72995 (Metoclopramide Intensol), held by Roxane Laboratories, was first approved by FDA on Jan 30, 1992, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 30, 1992 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metoclopramide IntensolEQ 10MG BASE/ML · concentrate;oral | Metoclopramide Hydrochloride | Discontinued |
| Apr 1, 1998 | Supplement 2Labeling | Approved | None posted |
| Aug 28, 1996 | Supplement 1Manufacturing | Approved | None posted |
| Jan 30, 1992 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters